Erik Harris
EVP & Chief Commercial Officer · 1 filing · Latest: Apr 16, 2026
Ultragenyx Pharmaceutical Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
RARE | Erik Harris | EVP & Chief Commercial Officer | Apr 16, 2026 | Grant/Award | $0.00 | 28,895 | — | 118,410 |